Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

Part of paid clinical trials in Austin, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT06109870
Status
Recruiting
Apply to this trial

Conditions

  • HPV

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • PRECEDE-PROCEED — BEHAVIORAL
    delivered self-sampling (CHWSS) to increase screening participation.

Study Details

Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it becomes cancet.

Key Dates

Start date
Oct 30, 2023
Status verified
Mar 2026
Primary completion
Aug 31, 2028
Completion
Aug 31, 2030

Study Design

Enrollment
920 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: PRECEDE-PROCEED
    To identify predisposing, enabling, and reinforcing factors that could influence women's decision to participate in self-sample HPV testing and diagnostic follow-up.

Primary Outcome Measure

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 [ Time Frame: through study completion; an average 1 year. ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of Texas at AustinAustinTexas78712
Marian Williams-Brown, MD
[email protected]
512-324-7036
Marian Williams-Brown, MD (PRINCIPAL_INVESTIGATOR)
M D Anderson Cancer CenterHoustonTexas77030
Jane Montealegre, M. D.
[email protected]
281-814-7118
Jane Montealegre, M. D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Austin, TX

By research site
University of Texas at Austin· Austin, TXM D Anderson Cancer Center· Houston, TX

Related Studies